Attached files
Exhibit 31.1
Certification Pursuant to Exchange Act Rule
13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
I, Ryan Drexler,
certify that:
|
1.
|
I have reviewed this Quarterly Report on Form
10-Q of MusclePharm Corporation;
|
|
2.
|
Based on my knowledge, this report does not
contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not
misleading with respect to the period covered by this
report;
|
|
3.
|
Based on my knowledge, the financial statements,
and other financial information included in this report, fairly
present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the
periods present in this report;
|
|
4.
|
The registrant’s other certifying officer
and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:
|
|
a)
|
Designed such disclosure controls and
procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being
prepared;
|
|
b)
|
Designed such internal control over financial
reporting, or caused such internal control over financial reporting
to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in
accordance with generally accepted accounting
principles;
|
|
c)
|
Evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented
in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and
|
|
d)
|
Disclosed in this report any change in the
registrant’s internal control over financing reporting that
occurred during the registrant’s fourth fiscal quarter that
has materially affected, or is reasonably likely to materially
affect, the registrant’s internal control over financial
reporting; and
|
|
5.
|
The registrant’s other certifying officer
and I have disclosed, based on my most recent evaluation of
internal control over financial reporting, to the
registrant’s auditors and the audit committee of the
registrant’s board of directors (or persons performing the
equivalent functions):
|
|
a)
|
All significant deficiencies and material
weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect
the registrant’s ability to record, process, summarize and
report financial information; and
|
|
b)
|
Any fraud, whether or not material, that
involves management or other employees who have a significant role
in the registrant’s internal control over financial
reporting.
|
|
|
|
|
Date: August 14, 2017
|
|
By:
|
/s/ Ryan
Drexler
|
|
|
|
Ryan Drexler
|
|
|
|
Chief Executive Officer and
President
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|